Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 7
1973 15
1974 5
1975 11
1976 13
1977 8
1978 5
1979 10
1980 21
1981 10
1982 12
1983 15
1984 18
1985 13
1986 13
1987 25
1988 29
1989 19
1990 26
1991 28
1992 25
1993 34
1994 30
1995 25
1996 30
1997 35
1998 21
1999 30
2000 25
2001 21
2002 19
2003 34
2004 23
2005 32
2006 31
2007 31
2008 31
2009 31
2010 36
2011 46
2012 58
2013 56
2014 51
2015 44
2016 40
2017 35
2018 32
2019 30
2020 30
2021 36
2022 38
2023 24
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

1,283 results

Results by year

Filters applied: . Clear all
Page 1
Glipizide. A review of the pharmacoeconomic implications of the extended-release formulation in type 2 diabetes mellitus.
Foster RH, Plosker GL. Foster RH, et al. Pharmacoeconomics. 2000 Sep;18(3):289-306. doi: 10.2165/00019053-200018030-00008. Pharmacoeconomics. 2000. PMID: 11147395 Review.
In patients with type 2 diabetes mellitus, glipizide GITS is at least as effective as the immediate-release formulation of glipizide in providing glycaemic control, and may have a greater effect on fasting plasma glucose levels. ...There are limitations to the prese …
In patients with type 2 diabetes mellitus, glipizide GITS is at least as effective as the immediate-release formulation of glipizi
Glipizide: an oral hypoglycemic drug.
Wensing G. Wensing G. Am J Med Sci. 1989 Jul;298(1):69-71. doi: 10.1097/00000441-198907000-00012. Am J Med Sci. 1989. PMID: 2665487 Review. No abstract available.
Glipizide Alleviates Periodontitis Pathogenicity via Inhibition of Angiogenesis, Osteoclastogenesis and M1/M2 Macrophage Ratio in Periodontal Tissue.
Guo X, Huang Z, Ge Q, Yang L, Liang D, Huang Y, Jiang Y, Pathak JL, Wang L, Ge L. Guo X, et al. Inflammation. 2023 Oct;46(5):1917-1931. doi: 10.1007/s10753-023-01850-1. Epub 2023 Jun 8. Inflammation. 2023. PMID: 37289398
Glipizide significantly inhibited osteoclast differentiation in vitro experiments. Glipizide treatment did not affect the oral microbiome of periodontitis mice. mRNA sequencing and KEGG analysis showed that glipizide activated PI3K/AKT signaling in LPS-stimul
Glipizide significantly inhibited osteoclast differentiation in vitro experiments. Glipizide treatment did not affect the oral
Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use.
Lebovitz HE. Lebovitz HE. Pharmacotherapy. 1985 Mar-Apr;5(2):63-77. doi: 10.1002/j.1875-9114.1985.tb03405.x. Pharmacotherapy. 1985. PMID: 3923454 Review.
Glipizide is a second-generation sulfonylurea in which the substitutions on the arylsulfonylurea nucleus are large, relatively nonpolar groups. ...The most important component of the antidiabetic action of glipizide is its effect in potentiating insulin action. G
Glipizide is a second-generation sulfonylurea in which the substitutions on the arylsulfonylurea nucleus are large, relatively nonpol
Glipizide: a review of its pharmacological properties and therapeutic use.
Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS. Brogden RN, et al. Drugs. 1979 Nov;18(5):329-53. doi: 10.2165/00003495-197918050-00001. Drugs. 1979. PMID: 389600 Review.
Glipizide is a 'second generation' oral hypoglycaemic agent similar in potency to glibenclamide. ...Glipizide is well tolerated, but careful adjustment of dosage and attention to diet may be needed to avoid hypoglycaemic symptoms a few hours after a single daily dos
Glipizide is a 'second generation' oral hypoglycaemic agent similar in potency to glibenclamide. ...Glipizide is well tolerate
Glipizide Combined with ANP Suppresses Breast Cancer Growth and Metastasis by Inhibiting Angiogenesis through VEGF/VEGFR2 Signaling.
Mao G, Zheng S, Li J, Liu X, Zhou Q, Cao J, Zhang Q, Zheng L, Wang L, Qi C. Mao G, et al. Anticancer Agents Med Chem. 2022;22(9):1735-1741. doi: 10.2174/1871520621666210910085733. Anticancer Agents Med Chem. 2022. PMID: 34515012
METHODS: This study aimed at investigating the effect of glipizide combined with ANP on breast cancer. Glipizide, ANP, or glipizide combined with ANP was intraperitoneally injected into MMTV-PyMT mice. ...Furthermore, the inhibitory effect of ANP combined wit …
METHODS: This study aimed at investigating the effect of glipizide combined with ANP on breast cancer. Glipizide, ANP, or g
Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD. Prendergast BD. Clin Pharm. 1984 Sep-Oct;3(5):473-85. Clin Pharm. 1984. PMID: 6435940 Review.
Glyburide and glipizide are well absorbed after oral administration. The absorption of glipizide is delayed by food; in contrast, glyburide absorption does not seem to be affected by administration with meals. ...Glyburide and glipizide appear to be comparabl …
Glyburide and glipizide are well absorbed after oral administration. The absorption of glipizide is delayed by food; in contra …
Glipizide: an overview.
Shuman CR. Shuman CR. Am J Med. 1983 Nov 30;75(5B):55-9. doi: 10.1016/0002-9343(83)90254-1. Am J Med. 1983. PMID: 6369968 Clinical Trial.
This is a brief summary of the extensive clinical experience with glipizide in the treatment of noninsulin-dependent diabetes mellitus. ...
This is a brief summary of the extensive clinical experience with glipizide in the treatment of noninsulin-dependent diabetes mellitu …
Glipizide ameliorates human poly(Q) mediated neurotoxicity by upregulating insulin signalling in Drosophila disease models.
Tandon S, Sarkar S. Tandon S, et al. Biochem Biophys Res Commun. 2023 Feb 19;645:88-96. doi: 10.1016/j.bbrc.2023.01.022. Epub 2023 Jan 13. Biochem Biophys Res Commun. 2023. PMID: 36680941
In view of the functional conservation of insulin signalling pathway in Drosophila and humans, our finding strongly suggests that glipizide can be repurposed as an effective treatment strategy against the neurodegenerative poly(Q) disorders. Also, with appropriate validati …
In view of the functional conservation of insulin signalling pathway in Drosophila and humans, our finding strongly suggests that glipizi
Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.
Li JH, Brenner LN, Kaur V, Figueroa K, Schroeder P, Huerta-Chagoya A; MAGIC Investigators; Diabetes Prevention Program (DPP) Research Group; Udler MS, Leong A, Mercader JM, Florez JC. Li JH, et al. Diabetologia. 2023 Jul;66(7):1260-1272. doi: 10.1007/s00125-023-05922-7. Epub 2023 May 26. Diabetologia. 2023. PMID: 37233759 Free PMC article.
The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH) examined the acute response to metformin and glipizide in order to identify new pharmacogenetic associations for the response to common glucose-lowering medic …
The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH) examined the acute respon …
1,283 results